Jan 10, 2024 / 11:45PM GMT
Sun Shubitha JPMorgan
Welcome, everyone. I'm [Sun Shubitha] with JP Morgan Healthcare. And we are pleased to have with us Dr. Elias Zerhouni, President and Vice Chairman of OPKO Health. For logistic purposes, please reserve any questions you may have after the end of this presentation.
Elias Zerhouni OPKO Health - Inc. - President & Vice Chairman
Well, thank you very much, very much, and thank you all for attending.
Last year, we presented the fact that OPKO had acquired a company called ModeX Therapeutics, of which I was a co-founder. And since then, we've achieved quite a bit of milestones across the company. A very important milestone occurred in 2023, which really announced a transformation, something that we've been strategizing to make happen over the previous years. Because one of the major milestone that was met this year was in fact, the approval of our long-acting growth hormone product, somatrogon, known as NGENLA, which was approved by the FDA in June and is one of the leading long-acting growth hormone product in the world, partner with Pfizer.
OPKO Health Inc at JPMorgan Healthcare Conference Transcript
Feb 08, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers